The European Commission has approved Saria’s acquisition of sole control over Quintet and Bioiberica, as well as its acquisition of joint control over Teeuwissen and Jagero II. Saria manufactures products using animal and vegetable by-products. Teeuwissen and Jagero II are holding companies involved in commercializing meat for human consumption.
The acquisitions of Teeuwissen and Jagero II create horizontal overlaps in the market for animal by-products in the United Kingdom and France. Yet the Commission found that other competitors, including overseas suppliers, and slaughterhouses pose enough competition so that Saria would not be able to increase prices as a result of the merger.
Source: EC Press Release
Related content: Reform of the EU Merger Regulation: Looking Out for the Minority (Christian Riis-Madsen, Sophia Stephanou & Killian Kehoe, O’Melveny & Myers)
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh